Market Pulse: Boston Scientific to pay Medinol $750M in settlement
23rd Sep 2005, 05:36 GMT
Boston Scientific will pay Israeli stent maker Medinol $750 mln as part of a settlement, both companies said.
Latest news from Angiography/ Cardiac Cath News from StratCenter.com:
- Thinking Systems Releases Enhanced PET-CT Functions for Its ThinkingPACS
- Tallahassee Memorial Hospital at the Forefront in Treatment of Heart Attack Patients
- Preliminary Long-Term Clinical Data Show Promising Results for the CYPHER Sirolimus-eluting Coronary Stent in Patients With Multi-Vessel Disease